Related Experiment Video
Updated: Jun 23, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Smad7 palmitoylation by the S-acyltransferase zDHHC17 enhances its inhibitory effect on TGF-β/Smad signaling
Oleksandr Voytyuk1, Yae Ohata1, Aristidis Moustakas1
1Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, Uppsala, Sweden.
Abstract:
Intracellular signaling by the pleiotropic cytokine transforming growth factor-β (TGF-β) is inhibited by Smad7 in a feedback control mechanism. The activity of Smad7 is tightly regulated by multiple post-translational modifications. Using resin-assisted capture and metabolic labeling methods, we show here that Smad7 is S-palmitoylated in mammary epithelial cell models that are widely studied because of their strong responses to TGF-β and their biological relevance to mammary development and tumor progression. S-palmitoylation of Smad7 is mediated by zDHHC17, a member of a family of 23 S-acyltransferase enzymes. Moreover, we identified four cysteine residues (Cys202, Cys225, Cys415, and Cys417) in Smad7 as palmitoylation acceptor sites. S-palmitoylation of Smad7 on Cys415 and Cys417 promoted the translocation of Smad7 from the nucleus to the cytoplasm, enhanced the stability of the Smad7 protein, and enforced its inhibitory effect on TGF-β-induced Smad transcriptional response. Thus, our findings reveal a new post-translational modification of Smad7, and highlight an important role of S-palmitoylation to enhance inhibition of TGF-β/Smad signaling by Smad7.
Insights
Transforming growth factor-β (TGF-β) signaling is regulated by Smad7. This study reveals Smad7 undergoes S-palmitoylation, a modification enhancing its inhibitory role in TGF-β/Smad pathways.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- Transforming growth factor-β (TGF-β) is a crucial cytokine regulating cell growth, differentiation, and development.
- Smad7 acts as a negative feedback regulator of TGF-β signaling.
- Post-translational modifications critically control Smad7 activity.
Purpose of the Study:
- To investigate novel post-translational modifications of Smad7.
- To elucidate the role of S-palmitoylation in Smad7 function.
- To understand the impact of Smad7 S-palmitoylation on TGF-β signaling in mammary epithelial cells.
Main Methods:
- Resin-assisted capture assays
- Metabolic labeling techniques
- Mammary epithelial cell models
- Identification of palmitoylation sites using mass spectrometry (implied)
Main Results:
- Smad7 is S-palmitoylated in mammary epithelial cells.
- zDHHC17 mediates Smad7 S-palmitoylation.
- Cysteine residues Cys415 and Cys417 are identified as key palmitoylation sites.
- S-palmitoylation promotes Smad7 nuclear-to-cytoplasmic translocation and enhances protein stability.
- Palmitoylated Smad7 more effectively inhibits TGF-β-induced Smad transcriptional responses.
Conclusions:
- S-palmitoylation is a novel post-translational modification of Smad7.
- This modification enhances Smad7's inhibitory capacity on TGF-β/Smad signaling.
- Findings highlight the importance of S-palmitoylation in regulating TGF-β signaling, with implications for mammary development and cancer progression.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway

